Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized prospective trial which addresses the question of whether use of an oral
hypoglycemic agent as an adjunct to diet therapy in women with mild gestational diabetes will
result in achieving euglycemia in a shorter period of time and, in turn, result in less
frequent maternal and neonatal morbidities. This study is designed to test the hypothesis
that in women with mild GDM, use of Glyburide in addition to diet and nutritional counseling
lowers mean infant birth weight by 200 grams as compared with diet and nutritional counseling
alone.